Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Ying‐nan Wang"'
Autor:
Qi Zhao, Feng Wang, Yan-Xing Chen, Shifu Chen, Yi-Chen Yao, Zhao-Lei Zeng, Teng-Jia Jiang, Ying-Nan Wang, Chen-Yi Wu, Ying Jing, You-Sheng Huang, Jing Zhang, Zi-Xian Wang, Ming-Ming He, Heng-Ying Pu, Zong-Jiong Mai, Qi-Nian Wu, Renwen Long, Xiaoni Zhang, Tanxiao Huang, Mingyan Xu, Miao-Zheng Qiu, Hui-Yan Luo, Yu-Hong Li, Dong-Shen Zhang, Wei-Hua Jia, Gong Chen, Pei-Rong Ding, Li-Ren Li, Zheng-Hai Lu, Zhi-Zhong Pan, Rui-Hua Xu
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
The ChangKang (Heathy Bowel) project was established to collect molecular and clinical information of a thousand Chinese colorectal cancer patients. Here, the authors present the genomic landscape of the ChangKang cohort and find a subgroup of patien
Externí odkaz:
https://doaj.org/article/ee0548bf4a574cba8d5b0964a7e38b91
Autor:
Zhao‐lei Zeng, Jia‐huan Lu, Yun Wang, Hui Sheng, Ying‐nan Wang, Zhan‐hong Chen, Qi‐nian Wu, Jia‐Bo Zheng, Yan‐xing Chen, Dong‐dong Yang, Kai Yu, Hai‐yu Mo, Jia‐jia Hu, Pei‐shan Hu, Ze‐xian Liu, Huai‐qiang Ju, Rui‐Hua Xu
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2423-2441 (2021)
Abstract Background Numerous reports on microRNAs have illustrated their role in tumor growth and metastasis. Recently, a new prognostic factor, miR‐125b‐2‐3p, has been identified for predicting chemotherapeutic sensitivity in advanced colorect
Externí odkaz:
https://doaj.org/article/39ec1ebf35c944a5aefe92e4611f5aa4
Autor:
Teng‐Jia Jiang, Fang Wang, Ying‐Nan Wang, Jia‐Jia Hu, Pei‐Rong Ding, Jun‐Zhong Lin, Zhi‐Zhong Pan, Gong Chen, Jian‐Yong Shao, Rui‐hua Xu, Qi Zhao, Feng Wang
Publikováno v:
Cancer Communications, Vol 40, Iss 11, Pp 620-632 (2020)
Abstract Background Inherited susceptibility accounts for nearly one‐third of colorectal cancer (CRC) predispositions and has an 80%‐100% lifetime risk of this disease. However, there are few data about germline mutations of hereditary CRC‐rela
Externí odkaz:
https://doaj.org/article/39a15601ed8e4c13860efc5397ddad0a
Autor:
Kui Liu, Yuan-Yuan Fang, Yan Deng, Wei Liu, Mei-Fang Wang, Jing-Ping Ma, Wei Xiao, Ying-Nan Wang, Min-Hua Zhong, Cheng-Hong Li, Guang-Cai Li, Hui-Guo Liu, Xiu-Yuan Hao, Pei-Fang Wei
Publikováno v:
Chinese Medical Journal, Vol 133, Iss 9, Pp 1025-1031 (2020)
Abstract. Background. The 2019 novel coronavirus (2019-nCoV) causing an outbreak of pneumonia in Wuhan, Hubei province of China was isolated in January 2020. This study aims to investigate its epidemiologic history, and analyze the clinical character
Externí odkaz:
https://doaj.org/article/5e676277f647467988028baaa9d4b1f6
Autor:
Yun Wang, Jia-Huan Lu, Qi-Nian Wu, Ying Jin, De-Shen Wang, Yan-Xing Chen, Jia Liu, Xiao-Jing Luo, Qi Meng, Heng-Ying Pu, Ying-Nan Wang, Pei-Shan Hu, Ze-Xian Liu, Zhao-Lei Zeng, Qi Zhao, Rong Deng, Xiao-Feng Zhu, Huai-Qiang Ju, Rui-Hua Xu
Publikováno v:
Molecular Cancer, Vol 18, Iss 1, Pp 1-18 (2019)
Abstract Background Long noncoding RNAs (lncRNAs) play nonnegligible roles in the epigenetic regulation of cancer cells. This study aimed to identify a specific lncRNA that promotes the colorectal cancer (CRC) progression and could be a potential the
Externí odkaz:
https://doaj.org/article/cd254d1cc795495d9725359a49bd532b
Autor:
Hao-Xiang Wu, Yan-Xing Chen, Zi-Xian Wang, Qi Zhao, Ming-Ming He, Ying-Nan Wang, Feng Wang, Rui-Hua Xu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Immune checkpoint inhibitors (ICIs) have achieved impressive success in different cancer types, yet responses vary and predictive biomarkers are urgently needed. Growing evidence points to a link between DNA methylation and anti-t
Externí odkaz:
https://doaj.org/article/a43975f7b4e8495897296fb29ffc8742
Autor:
Qi Zhao, Yan‐Xing Chen, Qi‐Nian Wu, Chao Zhang, Min Liu, Ying‐Nan Wang, Yan‐Fen Feng, Jia‐Jia Hu, Jian‐Hua Fu, Hong Yang, Jing‐Jing Qi, Zi‐Xian Wang, Yun‐Xin Lu, Hui Sheng, Ze‐Xian Liu, Zhi‐Xiang Zuo, Jian Zheng, Jing‐Ping Yun, Jin‐Xin Bei, Wei‐Hua Jia, Dong‐Xin Lin, Rui‐hua Xu, Feng Wang
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 10, Pp n/a-n/a (2020)
Abstract Objectives Although the genomic landscape of small‐cell carcinoma of the oesophagus (SCCE) has been dissected, its transcriptome‐level aberration and immune microenvironment status are unknown. Methods Using ultra‐deep whole transcript
Externí odkaz:
https://doaj.org/article/5bc0a44491a64c4c8dcbfdc59576f7df
Autor:
Ying-Nan Wang, 王英南
100
In recent years, the popularity of internet and broadband internet of digital technologies have turned television signal from analog into digital. Besides, the services of internet TV have changed from traditional broadband TV into internet
In recent years, the popularity of internet and broadband internet of digital technologies have turned television signal from analog into digital. Besides, the services of internet TV have changed from traditional broadband TV into internet
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/84002342379435971743
Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc
Autor:
Ying-Nan Wang, Dan-Yun Ruan, Zi-Xian Wang, Kai Yu, Dai-Lin Rong, Ze-Xian Liu, Feng Wang, Jia-Jia Hu, Ying Jin, Qi-Nian Wu, Heng-Ying Pu, Min Wang, Rui-Hua Xu, Zhao-Lei Zeng
Publikováno v:
Oncogene. 41:5266-5278
Dysregulated cholesterol metabolism is a hallmark of colorectal cancer (CRC). However, the usage of cholesterol-lowering agents seemed to have no benefit in CRC patients. In this study, we focused on the cholesterol-nuclear receptors (NRs) axis as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ddab9c70682bd8d0393e220c408e720
https://doi.org/10.1038/s41388-022-02515-3
https://doi.org/10.1038/s41388-022-02515-3
Autor:
Xiao-Li Wei, Shu-Qiang Yuan, Dan-Yun Ruan, Fenghua Wang, Rui-Hua Xu, Zi-Xian Wang, Yan-Xing Chen, Hao-Xiang Wu, Ying-Nan Wang
Publikováno v:
Gastroenterology Report
Background Due to its limited efficacy and potential toxicity, anti-PD-1 monoclonal antibody is not suitable for all advanced gastric cancer (AGC) patients and predictive biomarkers identifying patients who can benefit from it are urgently needed. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::465108a7d011c3ab5889cd6bdf28b023
http://europepmc.org/articles/PMC8677531
http://europepmc.org/articles/PMC8677531